Published in Vaccine Weekly, June 8th, 2011
"Multivariate regression analyses identified factors associated with potential PHR use. We obtained a 79% (n = 200) response rate. Many...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2011-06-08)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.